Literature DB >> 22985709

Evidence-based criteria for sarcopenia with clinically important weakness.

Stephanie Studenski1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22985709      PMCID： PMC4886746          DOI： 10.1016/j.semarthrit.2012.07.007

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN： 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  8 in total

1.  Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons.

Authors:  Marjolein Visser; Bret H Goodpaster; Stephen B Kritchevsky; Anne B Newman; Michael Nevitt; Susan M Rubin; Eleanor M Simonsick; Tamara B Harris
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-03       Impact factor: 6.053

Review 2.  Considerations in the development of drugs to treat sarcopenia.

Authors:  Eric P Brass; Kathy E Sietsema
Journal:  J Am Geriatr Soc       Date:  2011-03-01       Impact factor: 5.562

3.  Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women.

Authors:  M Visser; D J Deeg; P Lips; T B Harris; L M Bouter
Journal:  J Am Geriatr Soc       Date:  2000-04       Impact factor: 5.562

4.  Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study.

Authors:  Ian Janssen
Journal:  J Am Geriatr Soc       Date:  2006-01       Impact factor: 5.562

5.  Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort.

Authors:  Anne B Newman; Varant Kupelian; Marjolein Visser; Eleanor M Simonsick; Bret H Goodpaster; Stephen B Kritchevsky; Frances A Tylavsky; Susan M Rubin; Tamara B Harris
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-01       Impact factor: 6.053

6.  Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.

Authors:  Roger A Fielding; Bruno Vellas; William J Evans; Shalender Bhasin; John E Morley; Anne B Newman; Gabor Abellan van Kan; Sandrine Andrieu; Juergen Bauer; Denis Breuille; Tommy Cederholm; Julie Chandler; Capucine De Meynard; Lorenzo Donini; Tamara Harris; Aimo Kannt; Florence Keime Guibert; Graziano Onder; Dimitris Papanicolaou; Yves Rolland; Daniel Rooks; Cornel Sieber; Elisabeth Souhami; Sjors Verlaan; Mauro Zamboni
Journal:  J Am Med Dir Assoc       Date:  2011-03-04       Impact factor: 4.669

7.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

Review 8.  Epidemiology and consequences of sarcopenia.

Authors:  G Abellan van Kan
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075
  8 in total
  3 in total

1.  Sarcopenia and frailty in elderly trauma patients.

Authors:  Berry Fairchild; Travis P Webb; Qun Xiang; Sergey Tarima; Karen J Brasel
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

Review 2.  Tools in the assessment of sarcopenia.

Authors:  C Cooper; R Fielding; M Visser; L J van Loon; Y Rolland; E Orwoll; K Reid; S Boonen; W Dere; S Epstein; B Mitlak; Y Tsouderos; A A Sayer; R Rizzoli; J Y Reginster; J A Kanis
Journal:  Calcif Tissue Int       Date:  2013-07-11       Impact factor: 4.333

3.  Biomarkers in nutrition: new frontiers in research and application.

Authors:  Gerald F Combs; Paula R Trumbo; Michelle C McKinley; John Milner; Stephanie Studenski; Takeshi Kimura; Steven M Watkins; Daniel J Raiten
Journal:  Ann N Y Acad Sci       Date:  2013-03       Impact factor: 5.691
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.